This inventor holds 2 USPTO granted patents. Top assignee: Kabivitrum Ab. Active years: 1988-1989.
Company Filing History:
Years Active: 1988-1989
Title: Kerstin E Larsen: Innovator in Hemophilia Treatment
Introduction
Kerstin E Larsen is a notable inventor based in Lidingo, Sweden. She has made significant contributions to the field of biotechnology, particularly in the treatment of hemophilia. With a focus on biologically active fragments of human antihemophilic factor, her work has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
Kerstin E Larsen holds 2 patents related to her innovative research. Her latest patents include "Biologically active fragments of human antihemophilic factor and method," which details novel, biologically active fragments of human antihemophilic factor. This patent outlines processes for their preparation, pharmaceutical preparations containing them, and the use of such fragments in the treatment of patients suffering from hemophilia.
Career Highlights
Kerstin has established herself as a key figure in her field through her groundbreaking research and patent contributions. Her work at Kabivitrum AB has allowed her to focus on developing effective treatments for hemophilia, showcasing her dedication to improving patient outcomes.
Collaborations
Throughout her career, Kerstin has collaborated with esteemed colleagues, including Lars-Olof Andersson and Nanna Forsman. These partnerships have further enhanced her research and development efforts in the biotechnology sector.
Conclusion
Kerstin E Larsen's innovative work in the field of hemophilia treatment exemplifies her commitment to advancing medical science. Her patents and collaborations highlight her significant contributions to biotechnology, making her a prominent figure in the industry.